Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nevirapine Resistance in Early HIV
NCT00000747Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Primary completion
- Dec 1994
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nevirapine in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00000747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000747.